There’s a particular kind of anxiety that comes with a fertility referral. You’ve been trying. You’ve done the tracking, taken the vitamins, cleared your calendar around ovulation. And now someone is handing you a requisition form for “diagnostic testing” and you’re not sure whether you want the results or not.
The workup follows a clear logic: least invasive first, answer the big questions before asking the harder ones. Understanding what each test is actually looking for — and what it isn’t — makes the whole process less like a verdict and more like information.
Here’s what to expect.
When to seek a fertility evaluation
The American Society for Reproductive Medicine (ASRM) defines infertility as not conceiving after 12 months of regular unprotected sex if you’re under 35, or after 6 months if you’re 35 or older. Earlier evaluation makes sense if you have irregular or absent periods, painful cycles, known endometriosis, prior pelvic surgery or infection, or a partner with known sperm issues.
These aren’t arbitrary thresholds. They reflect how conception probability shifts over time and with age. If something in your history suggests a specific obstacle, waiting doesn’t help.
A 2021 review in Human Reproduction Update found that fertility patients have anxiety and depression rates comparable to those seen in serious medical illness — which puts into context why even requesting an evaluation can feel heavy. That reaction isn’t disproportionate. This is hard.
What the first appointment actually looks like
Before any bloodwork or imaging, most evaluations start with conversation. ASRM guidelines on fertility evaluation put a detailed history and physical exam at the foundation, not as an afterthought.
You’ll likely be asked about your menstrual history (cycle length, flow, pain), how long you’ve been trying and how often you’re having sex, prior pregnancies or losses, medical conditions, medications and surgeries, and family history of early menopause, clotting disorders, or genetic conditions.
If you have a partner who produces sperm, their history matters too: prior paternity, surgeries (hernia repair, testicular surgery), infections, testosterone use, smoking, heat exposure. Clinical reviews note that male factor contributes to about a third of infertility cases, which is why semen analysis belongs in the initial evaluation rather than added at the end if everything else looks fine.
Initial bloodwork typically covers early-cycle hormones (FSH, LH, estradiol), thyroid and prolactin levels, and preconception screening labs including blood type, CBC, and infectious disease testing. If there are signs of PCOS, androgens or glucose testing may be added. ASRM encourages using existing records where possible to avoid repeating tests unnecessarily — so bring what you have.
Ovulation: confirming it’s happening
If your cycles are regular — between 21 and 35 days — your clinician may not need additional testing to confirm ovulation. Regular cycles generally imply ovulatory cycles in the absence of other hormonal symptoms. ASRM evaluation guidance notes this directly.
If confirmation is needed, the standard approach is a mid-luteal progesterone draw — sometimes called a “day 21” test, though what matters is that it’s taken about seven days before your next expected period, not on a specific calendar date.
If there are signs of thyroid dysfunction, elevated prolactin, or PCOS, those get investigated separately. Each can interfere with ovulation through different mechanisms. Home data you’ve already gathered — cycle app logs, ovulation predictor kit results, basal body temperature charts — can be useful here. Major medical associations now treat these as legitimate data sources, not just anecdotes.
Ovarian reserve: what it measures and what it doesn’t
Ovarian reserve testing gives an estimate of your near-term egg supply and how your ovaries are likely to respond to stimulation. It does not count your eggs one by one, and it does not predict whether you can conceive.
The three standard markers:
AMH (anti-Müllerian hormone) is a blood test reflecting the pool of small growing follicles. It can be drawn at any point in your cycle. Day-3 FSH and estradiol give a sense of how hard the brain is working to stimulate the ovaries — higher FSH can indicate reduced reserve. Antral follicle count (AFC) is a transvaginal ultrasound that counts small resting follicles in each ovary.
ASRM guidance is clear: these markers inform counseling and treatment planning, but they “do not reliably predict failure to conceive.” A lower AMH may mean your ovaries will produce fewer eggs in response to stimulation — that’s useful for treatment decisions. It doesn’t mean pregnancy isn’t possible.
The inverse is also true. A reassuring reserve result doesn’t guarantee a straightforward path. And none of these tests say anything about egg quality. There is currently no clinical test for that.
Uterus and fallopian tubes: the structural picture
Two questions: does the uterus look like a viable environment for implantation, and are the fallopian tubes open?
Pelvic ultrasound is usually transvaginal and often the first imaging you’ll have. It lets your clinician look for fibroids, ovarian cysts, polycystic-appearing ovaries, or structural differences like a septate uterus, and also gives the antral follicle count. Clinical reviews describe it as a core part of the workup because it surfaces anatomic issues that may affect cycles or implantation.
Hysterosalpingogram (HSG) is an X-ray procedure where contrast dye is passed through the cervix into the uterus and fallopian tubes. The Cleveland Clinic describes it as a way to visualize the shape of the uterine cavity and whether dye flows freely through the tubes. You lie on an X-ray table, a speculum is placed, a thin catheter introduces the dye. Most people experience cramping during the procedure. Taking an over-the-counter pain reliever beforehand is usually recommended.
Saline infusion sonogram (SHG) is sometimes ordered instead of or alongside an HSG. Clinical guidance notes it’s useful for evaluating the uterine cavity with less radiation exposure and lower infection risk. Recent guidelines increasingly favor it for assessing uterine abnormalities.
Semen analysis: what it covers
A standard semen analysis looks at volume, concentration (sperm per milliliter), motility (how many are moving and how well), and morphology (shape). Sometimes vitality and other parameters are included.
Sample collection requires 2–4 days of abstinence before providing a sample under specific conditions. If results are abnormal, they’re usually repeated — a single result isn’t definitive. If there are consistent concerns, a urologist specializing in male infertility may be brought in.
At-home screening tools like YO Home Sperm Test and ExSeed can give an early read on sperm health before a clinic visit. A Cleveland Clinic evaluation of the YO device found it “a user-friendly, accurate way to screen samples at home” — while noting that lab-based semen analysis remains the standard for diagnosis and treatment decisions.
More invasive tests: when they come up
Laparoscopy, hysteroscopy, and genetic testing are not default parts of the initial workup. They’re reserved for specific indications based on what earlier testing reveals.
Laparoscopy may come up if there’s significant pelvic pain, suspected endometriosis, or something on imaging worth investigating directly. Hysteroscopy lets a clinician look inside the uterus and potentially treat polyps, fibroids, or scarring in the same procedure. Genetic testing (karyotyping) typically gets discussed when sperm is very low or absent, there’s a history of recurrent pregnancy loss, or a chromosomal condition is suspected.
A good clinician will explain why a test is being recommended, how it might change your options, and whether it’s time-sensitive or something you can take time to consider.
Your body’s stress state: the signal that labs miss
Standard labs check hormone levels, anatomy, and sperm. What they don’t capture is how physiological stress is affecting your reproductive system in real time.
Chronic activation of the HPA axis — your body’s stress response system — suppresses GnRH pulses, which reduces LH and FSH signaling to the ovaries. That affects ovulation quality and progesterone production. This isn’t about feeling anxious. It’s a measurable physiological process that doesn’t appear on any panel in a standard workup.
This is where adaptive capacity — your body’s ability to manage physiological stress while maintaining reproductive function — becomes relevant. The Monday Fertility wearable provides continuous monitoring across 50+ biomarkers, including heart rate variability, nervous system regulation, and stress-recovery patterns, and translates that data into a Fertility Index that reflects how your body is actually responding over time. Going into a workup with that picture already in hand gives you and your care team more to work with than labs alone.
The emotional side
That same 2021 Human Reproduction Update review found that when patients receive clear information, realistic expectations, and emotional support, they cope better with evaluation and treatment — even when outcomes are uncertain.
A 2023 trial of a self-compassion-based program for fertility patients found that participants had lower anxiety and depression and greater confidence in managing treatment compared with usual care. A separate mindfulness-based study found reductions in infertility-related stress and improved wellbeing. Neither program claims to improve conception rates — the point is that your emotional experience during this process is worth attending to on its own terms.
Practically: write your questions down before appointments so you’re not trying to remember them mid-conversation. Bring someone if you can. Ask for plain language when you need it. Plan something low-key afterward.
How to prepare
Gather your records. Prior labs, imaging, and operative notes can streamline the workup and reduce redundant testing. Log what you already have — cycle data, OPK results, BBT charts. Write your questions down. ASRM explicitly recommends tailoring the pace of evaluation to the patient’s preferences, which means your questions and limits are a legitimate part of the process. And build your support. Research links strong social support with better coping across the fertility journey — which doesn’t have to mean a support group. It can just mean one person who knows what you’re going through.
What these results are — and aren’t
FSH, AMH, AFC, tube patency, semen parameters — each tells you something specific and limited about your reproductive system right now. They don’t predict the future with certainty. They don’t determine your worth as a parent.
What they do is give you and your care team a clearer picture of where to focus. That’s the point: not a pass/fail assessment, but a foundation for decisions based on your body’s signals rather than guesswork.
You don’t need to come in with everything figured out. You just need to show up.
